Expression of Pdcd4 tumor suppressor in human melanoma cells

Anticancer Research

Volumn 34, Issue 5, 2014, Pages 2315-2318

  Vikhreva, Polina N ^a   Korobko, Igor V ^a  

^a INSTITUTE OF GENE BIOLOGY   (Russian Federation)

Author keywords

Akt signaling pathway; Cell lines; Expression; Melanoma; Pdcd4; Tumor suppressor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MICRORNA; MICRORNA 183; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROGRAMMED CELL DEATH 4; PROTEIN KINASE B; RAPAMYCIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; PDCD4 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ADVANCED CANCER; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; MELANOCYTE; MELANOMA; MELANOMA CELL; MELANOMA CELL LINE; MOLECULAR TYPING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; TUMOR GROWTH; UBIQUITINATION; UPREGULATION; WESTERN BLOTTING; AKT SIGNALING PATHWAY; BIOSYNTHESIS; CELL LINES; EXPRESSION; GENETICS; METABOLISM; PDCD4; PHYSIOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR;

AKT SIGNALING PATHWAY; CELL LINES; EXPRESSION; MELANOMA; PDCD4; TUMOR SUPPRESSOR;

APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CELL LINE, TUMOR; HUMANS; MELANOCYTES; MELANOMA; PROTO-ONCOGENE PROTEINS C-AKT; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84902950991     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mudduluru G, Medved F, Grobholz R, Jost C, Gruber A, Leupold JH, Post S, Jansen A, Colburn NH and Allgayer H: Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 110: 1697-1707, 2007.
2. Kalinichenko S V, Kopantzev EP, Korobko EV, Palgova I V, Zavalishina LE, Bateva M V, Petrov AN, Frank GA, Sverdlov ED and Korobko IV: Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors. Lung Cancer 62: 173-180, 2008.
3. Chen Y, Knösel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S, Ozaki I and Petersen I: Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 200: 640-646, 2003.
4. Gao F, Zhang P, Zhou C, Li J, Wang Q, Zhu F, Ma C, Sun W and Zhang L: Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. Oncol Rep 17: 123-128, 2007.
5. Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y, Ideguchi H, Yamamoto K and Matsuhashi S: Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25: 6101-6112, 2006.
6. Reis PP, Tomenson M, Cervigne NK, Machado J, Jurisica I, Pintilie M, Sukhai MA, Perez-Ordonez B, Grénman R, Gilbert RW, Gullane PJ, Irish JC and Kamel-Reid S: Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol Cancer 9: article 238, 2010.
7. Wei NA, Liu SS, Leung TH, Tam KF, Liao XY, Cheung AN, Chan KK and Ngan HY: Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer. Mol Cancer 8: article 70, 2009.
8. Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo YY: MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359, 2008.
9. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136, 2008.
10. Leupold JH, Yang HS, Colburn NH, Asangani I, Post S and Allgayer H: Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 26: 4550-4562, 2007.
11. Afonja O, Juste D, Das S, Matsuhashi S and Samuels HH: Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 23: 8135-8145, 2004.
12. Gaur AB, Holbeck SL, Colburn NH and Israel MA: Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro Oncol 13: 580-590, 2011.
13. Hwang SK, Minai-Tehrani A, Lim HT, Shin JY, An GH, Lee KH, Park KR, Kim YS, Beck JR Jr, Yang HS and Cho MH: Decreased level of PDCD4 (programmed cell death 4) protein activated cell proliferation in the lung of A/J mouse. J Aerosol Med Pulm Drug Deliv 23: 285-293, 2010.
14. Hilliard A, Hilliard B, Zheng SJ, Sun H, Miwa T, Song W, Göke R and Chen YH: Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J Immunol 177: 8095-8102, 2006.
15. Schmid T, Jansen AP, Baker AR, Hegamyer G, Hagan JP and Colburn NH: Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Res 68: 1254-1260, 2008.
16. Jansen AP, Camalier CE and Colburn NH: Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 65: 6034-6041, 2005.
17. Mikhailova IN, Lukashina MI, Baryshnikov AYu, Morozova LF, Burova OS, Palkina TN, Kozlov AM, Golubeva VA, Cheremushkin EA, Doroshenko MB, Demidov LV, Kiselev SL, Larin SS and Georgiev GP: Melanoma cell lines as the basis for antitumor vaccine preparation. Vestn Ross Akad Med Nauk 7: 37-40, 2005.
18. Mikhaylova IN, Kovalevsky DA, Morozova LF, Golubeva VA, Cheremushkin EA, Lukashina MI, Voronina ES, Burova OS, Utyashev IA, Kiselev SL, Demidov LV, Beabealashvilli RSh and Baryshnikov AY: Cancer/testis genes expression in human melanoma cell lines. Melanoma Res 18: 303-313, 2008.
19. Berezhnoi AE, Chernisheva AD, Zakeeva IR, Danilova AB, Danilov AO, Moiseenko VM, Geraghty D, Gnuchev NV, Georgiev GP, Kibardin AV and Larin SS: HLA-E molecule induction on the surface of tumor cells protects them from cytotoxic lymphocytes. Vopr Onkol 55: 224-229, 2009.
20. Allgayer H: Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 73: 185-191, 2010.
21. Howell PM Jr., Li X, Riker AI and Xi Y: MicroRNA in Melanoma. Ochsner J 10: 83-92, 2010.
22. Robertson GP: Functional and therapeutic significance of Akt deregulation in malignant melanoma. Cancer Metastasis Rev 24: 273-285, 2005.
23. Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE and Pagano M: S6K1-And betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth, " Science 314: 467-471, 2006.
24. Vikhreva PN, Shepelev MV and Korobko IV: mTOR-dependent transcriptional repression of Pdcd4 tumor suppressor in lung cancer cells. Biochim Biophys Acta DOI: 10.1016/j.bbagrm.2013.12.001, 2013.
25. Vidwans SJ, Flaherty KT, Fisher DE, Tenenbaum JM, Travers MD and Shrager J: A melanoma molecular disease model. PLoS One 6: e18257, 2011.